Cargando...
Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma
The GAUDI study assessed safety and preliminary efficacy of induction therapy with obinutuzumab plus chemotherapy, followed by maintenance therapy with obinutuzumab alone, in previously untreated patients with follicular lymphoma. Assignment to chemotherapy was decided on a per-center basis before t...
Guardado en:
Publicado en: | Haematologica |
---|---|
Autores principales: | , , , , , , , , |
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
Ferrata Storti Foundation
2017
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5395117/ https://ncbi.nlm.nih.gov/pubmed/28011903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.152272 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|